[BGLC] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
09-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -14.75%
YoY- -79.49%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 3,070 53 24 22 28 9 92 934.28%
PBT -47 -96 -50 -69 -60 -63 -89 -34.64%
Tax 1 -4 -28 1 1 0 0 -
NP 1,070 -93 -22 -70 -61 -63 -89 -
Tax Rate - - - - - - - -
Total Cost 2,000 146 46 92 90 72 181 395.37%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 34.84 -174.51 -91.13 -325.24 -218.84 -669.43 -97.09 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS 0.12 -0.01 -0.00 -0.01 -0.01 -0.01 -0.02 -
EPS Diluted 0.12 -0.01 -0.00 -0.01 -0.01 -0.01 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.